These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 31029168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
    Mafficini A, Simbolo M, Parisi A, Rusev B, Luchini C, Cataldo I, Piazzola E, Sperandio N, Turri G, Franchi M, Tortora G, Bovo C, Lawlor RT, Scarpa A.
    Oncotarget; 2016 Jan 12; 7(2):1076-83. PubMed ID: 26745875
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
    Lee A, Kang J, Lee H, Lee YS, Choi YJ, Lee KH, Nistala GJ, Scafe CR, Choi J, Yoo J, Han M D E, Kim Y, Kim M.
    Pathol Res Pract; 2019 Nov 12; 215(11):152595. PubMed ID: 31570282
    [Abstract] [Full Text] [Related]

  • 5. Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.
    Badoer C, Garrec C, Goossens D, Ellison G, Mills J, Dzial M, El Housni H, Berwouts S, Concolino P, Guibert-Le Guevellou V, Delnatte C, Del Favero J, Capoluongo E, Bézieau S.
    Oncotarget; 2016 Dec 06; 7(49):81357-81366. PubMed ID: 27793035
    [Abstract] [Full Text] [Related]

  • 6. Validation of multi-gene panel next-generation sequencing for the detection of BRCA mutation in formalin-fixed, paraffin-embedded epithelial ovarian cancer tissues.
    Kim ET, Jeong HE, Yoon HJ, Kim KH, Suh DS.
    Taiwan J Obstet Gynecol; 2023 Jan 06; 62(1):66-70. PubMed ID: 36720553
    [Abstract] [Full Text] [Related]

  • 7. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
    Schmidt AY, Hansen TVO, Ahlborn LB, Jønson L, Yde CW, Nielsen FC.
    J Mol Diagn; 2017 Nov 06; 19(6):809-816. PubMed ID: 28822785
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.
    Chao A, Chang TC, Lapke N, Jung SM, Chi P, Chen CH, Yang LY, Lin CT, Huang HJ, Chou HH, Liou JD, Chen SJ, Wang TH, Lai CH.
    Oncotarget; 2016 Dec 20; 7(51):85529-85541. PubMed ID: 27907908
    [Abstract] [Full Text] [Related]

  • 9. Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling.
    Petersen AH, Aagaard MM, Nielsen HR, Steffensen KD, Waldstrøm M, Bojesen A.
    Eur J Hum Genet; 2016 Aug 20; 24(8):1104-11. PubMed ID: 26733283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.
    Weren RD, Mensenkamp AR, Simons M, Eijkelenboom A, Sie AS, Ouchene H, van Asseldonk M, Gomez-Garcia EB, Blok MJ, de Hullu JA, Nelen MR, Hoischen A, Bulten J, Tops BB, Hoogerbrugge N, Ligtenberg MJ.
    Hum Mutat; 2017 Feb 20; 38(2):226-235. PubMed ID: 27767231
    [Abstract] [Full Text] [Related]

  • 12. A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing.
    Ellison G, Huang S, Carr H, Wallace A, Ahdesmaki M, Bhaskar S, Mills J.
    BMC Clin Pathol; 2015 Feb 20; 15():5. PubMed ID: 25859162
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I, Merola F, Biasiotto G, Archetti S, Spinelli E, Di Lorenzo D.
    Exp Mol Pathol; 2017 Apr 20; 102(2):314-320. PubMed ID: 28263838
    [Abstract] [Full Text] [Related]

  • 14. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
    Han E, Yoo J, Chae H, Lee S, Kim DH, Kim KJ, Kim Y, Kim M.
    Clin Chim Acta; 2020 Jun 20; 505():49-54. PubMed ID: 32092317
    [Abstract] [Full Text] [Related]

  • 15. [Testing of mutations in BRCA1 and BRCA2 genes in tumor tissues - possibilities and limitations].
    Vošmiková H, Ryška A, Sieglová K, Laco J.
    Cesk Patol; 2016 Jun 20; 52(4):210-214. PubMed ID: 27869447
    [Abstract] [Full Text] [Related]

  • 16. Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing.
    Sim WC, Lee CY, Richards R, Bettens K, Mottier V, Goh LL.
    Exp Mol Pathol; 2020 Oct 20; 116():104483. PubMed ID: 32531196
    [Abstract] [Full Text] [Related]

  • 17. A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.
    Scaglione GL, Concolino P, De Bonis M, De Paolis E, Minucci A, Ferrandina G, Scambia G, Capoluongo E.
    Int J Mol Sci; 2018 Mar 23; 19(4):. PubMed ID: 29570666
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A, Balabas A, Paziewska A, Kulecka M, Nowakowska D, Mikula M, Ostrowski J.
    BMC Med Genomics; 2015 May 07; 8():19. PubMed ID: 25948282
    [Abstract] [Full Text] [Related]

  • 20. BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes.
    Kechin A, Khrapov E, Boyarskikh U, Kel A, Filipenko M.
    Comput Biol Chem; 2018 Dec 07; 77():297-306. PubMed ID: 30408727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.